One-year follow-up results of LANDMARC study – disclosed at ADA 2021

LANDMARC - India’s first nationwide longitudinal real-world study on >6000 Indian T2DM patients, monitored longitudinally over a period of 3 years. This is the first of its kind large scale prospective registry, initiated in 2017, which has been designed to understand the micro- and macrovascular complications, glycemic control, and time to treatment adaptation in Indian subjects with T2DM. The 1-year follow-up results disclosed at the ADA 2021 have been shown in the video.

MAT-IN-2104336 12/2021